NCT06320600

Precision Medicine of Diabetes Program in China

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 120,000 (estimated)
• Sponsor: Second Xiangya Hospital of Central South University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The prevalence of diabetes has been increasing year by year. According to the International Diabetes Federation (IDF) statistics in 2021, the global number of people with diabetes has reached 537 million. The patient population is large and heterogeneous, and precise diagnosis and treatment of diabetes patients have been a focus of attention. The objective of this study is to clarify the current status of precision classification and diagnosis of diabetes patients through retrospective and prospective cohort studies, and to establish a model for precision classification and diagnosis of diabetes, improving the accuracy of diabetes classification and diagnosis; based on big data of precision medicine for diabetes patients and follow-up cohorts, to establish precise diagnostic, therapeutic, and predictive methods for diabetes; and through multi-omics data analysis, to explore the potential pathogenesis of diabetes, explaining the heterogeneity of patients, and guiding individualized treatment for patients.

Conditions

• Diabetes

Interventions

Type	Name	Description
OTHER	no intervention	It's an observational study, no intervention included

Timeline

• Start date: 2023-07-01
• Primary completion: 2028-12-01
• Completion: 2028-12-01
• First posted: 2024-03-20
• Last updated: 2024-03-20

Locations

1 site across 1 country: China